Owner F. Hoffmann-La Roche AG

Inventors Schulz-Gasch, Tanja; Wright, Matthew; Obst Sander, Ulrike; Dehmlow, Henrietta

Agent Spruson & Ferguson

Pub. Number AU-A-2009256679

PCT Pub. Number WO2009/150109

Priority 08158075.5 11.06.08 EP

Filing date 8 June 2009

Wipo publication date 17 December 2009

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4166 (2006.01)

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 233/38 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms